These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 32211422)
1. Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling. Parichatikanond W; Luangmonkong T; Mangmool S; Kurose H Front Cardiovasc Med; 2020; 7():34. PubMed ID: 32211422 [TBL] [Abstract][Full Text] [Related]
2. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts. Cho N; Razipour SE; McCain ML Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479 [TBL] [Abstract][Full Text] [Related]
3. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway. Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814 [TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Kapoun AM; Liang F; O'Young G; Damm DL; Quon D; White RT; Munson K; Lam A; Schreiner GF; Protter AA Circ Res; 2004 Mar; 94(4):453-61. PubMed ID: 14726474 [TBL] [Abstract][Full Text] [Related]
6. Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts. Shi X; Young CD; Zhou H; Wang X Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322749 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction. Zhou Y; Shiok TC; Richards AM; Wang P J Mol Cell Cardiol; 2018 Aug; 121():266-276. PubMed ID: 30053527 [TBL] [Abstract][Full Text] [Related]
8. EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling. Su SA; Yang D; Wu Y; Xie Y; Zhu W; Cai Z; Shen J; Fu Z; Wang Y; Jia L; Wang Y; Wang JA; Xiang M Circ Res; 2017 Sep; 121(6):617-627. PubMed ID: 28743805 [TBL] [Abstract][Full Text] [Related]
9. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Samuel CS; Unemori EN; Mookerjee I; Bathgate RA; Layfield SL; Mak J; Tregear GW; Du XJ Endocrinology; 2004 Sep; 145(9):4125-33. PubMed ID: 15155573 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis. Działo E; Tkacz K; Błyszczuk P Acta Biochim Pol; 2018; 65(3):341-349. PubMed ID: 30040870 [TBL] [Abstract][Full Text] [Related]
11. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614 [TBL] [Abstract][Full Text] [Related]
12. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts. Liu X; Sun SQ; Hassid A; Ostrom RS Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941 [TBL] [Abstract][Full Text] [Related]
14. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis. Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076 [TBL] [Abstract][Full Text] [Related]
15. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway. Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434 [TBL] [Abstract][Full Text] [Related]
16. Antifibrotic therapies to control cardiac fibrosis. Fan Z; Guan J Biomater Res; 2016; 20():13. PubMed ID: 27226899 [TBL] [Abstract][Full Text] [Related]